Medtronic plc — Director's Dealing 2021

Jun 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-05-28

Reporting Person: Wall Brett A. (EVP & Pres Neuroscience)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-28	Ordinary Shares	M	12300	$47.00	Acquired	31315	Direct
2021-05-28	Ordinary Shares	F	7355	$126.59	Disposed	23960	Direct
2021-06-01	Ordinary Shares	S	2473	$128.07	Disposed	21487	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-28	Stock Option (Right to Buy)	$47.00	M	12300	Disposed	2023-12-01	Ordinary Shares (12300)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This balance increased by 300 shares due to exempt transactions such as dividend reinvestment.

F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.